Skip to main content

Table 1 Patients characteristics

From: Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

  No.
Patients 65
Mean age(years) 64(range, 41-76)
Sex(male/female)  
Male 61
Female 4
Smoking history 21
Histological type  
Well differentiated 21
Moderately differentiated 28
Poorly differentiated 16